Day: April 22, 2020

Bezons, le 22 avril 2020 – 18h30 – Le Directoire de RIBER, réuni le 21 avril 2020, a décidé de soumettre à l’Assemblée Générale mixte du 23 juin 2020 le projet de transfert de la cotation des titres de la société du marché réglementé d’Euronext vers le marché Euronext Growth à Paris.Raisons du projet de transfertRIBER projette de transférer la cotation de ses titres sur le marché Euronext Growth à Paris. Ce projet vise à lui permettre d’être coté sur un marché plus approprié à la taille de l’entreprise. Le transfert sur Euronext Growth devrait ainsi simplifier le fonctionnement de la société et diminuer ses coûts, tout en lui permettant de continuer à bénéficier des attraits des marchés financiers.Conditions du projet de transfertLa soumission à l’Assemblée Générale des actionnaires de ce projet de transfert de la cotation...

Albion Development VCT PLCInterim Management StatementLEI Code 213800FDDMBD9QLHLB38IntroductionI present Albion Development VCT PLC (the “Company”)’s interim management statement for the period from 1 January 2020 to 31 March 2020.Impact of coronavirus (Covid-19) and Net asset valueThe Board has been monitoring the ongoing disruption caused by the coronavirus (Covid-19) pandemic and its current impact on portfolio companies. These are unprecedented times with major uncertainty as to the ongoing economic and societal impact of the coronavirus (Covid-19) pandemic, the extent of which is still unknown.In light of this, the Company announces its unaudited net asset value (NAV) as at 31 March 2020 of £71.85 million or 77.66 pence per share (excluding treasury shares), which represents a decrease of 5.81 pence per share (7.0 per cent.) since...

ALBION ENTERPRISE VCT PLCLEI Code: 213800OVSRDHRJBMO720NAV AnnouncementIntroductionThis announcement contains unaudited information. The audited Annual Report and Financial Statements for the year ended 31 March 2020 is expected to be released in June 2020. The final audited net asset value (NAV) may differ to this unaudited NAV.Impact of coronavirus (Covid-19) and Net asset valueThe Board has been monitoring the ongoing disruption caused by the coronavirus (Covid-19) pandemic and its current impact on portfolio companies. These are unprecedented times with major uncertainty as to the ongoing economic and societal impact of the coronavirus (Covid-19) pandemic, the extent of which is still unknown.In light of this, the Company announces its unaudited NAV as at 31 March 2020 of £72.5 million or 106.54 pence per share (excluding treasury shares)....

OCTOPUS AIM VCT 2 PLC2020 ANNUAL GENERAL MEETING (AGM) CHANGE OF ARRANGEMENTS22 April 2020Octopus AIM VCT 2 plc announces that in light of the current COVID-19 stay at home measures in the UK, the AGM will be run as a closed meeting and shareholders will not be able to attend in person. Shareholders attempting to attend the AGM will be refused entry.Instead of attending this year’s AGM, shareholders are asked to exercise their votes by submitting their proxy electronically or by post.In addition, should a shareholder have a question that they would have raised at the meeting, we ask that they send it by email to AIMVCT2AGM@Octopusinvestments.com in advance of the meeting.For further information please contact:Graham VenablesOctopus Company Secretarial Services Limited020 3935 3803

BOCA RATON, Fla., April 22, 2020 (GLOBE NEWSWIRE) — Newtek Business Services Corp., (Nasdaq: NEWT), an internally managed business development company (“BDC”), today announced that it will report its first quarter 2020 financial results after the market closes on Thursday, May 7, 2020.  A conference call to discuss these results will be hosted by Barry Sloane, Chief Executive Officer, and Christopher Towers, Chief Accounting Officer, the following day, Friday, May 8, 2020 at 8:30 am ET.  The live conference call can be accessed by dialing (877) 303-6993 or (760) 666-3611.A live webcast of the call and the corresponding presentation will be available in the ‘Events & Presentations’ section of the Investor Relations portion of Newtek’s website at http://investor.newtekbusinessservices.com/events-and-presentations. A replay of...

Amiens, le 22 Avril  2020La Caisse Régionale de Crédit Agricole Mutuel Brie Picardie informe le public que son Rapport  Financier Annuel 2019 a été communiqué à l’AMF. Ce rapport est disponible sur le site Internet https://www.ca-briepicardie.fr/, dans la rubrique « Informations réglementées ».Ce Rapport Financier Annuel contient :– la présentation de la Caisse Régionale– la Déclaration de Performance Extra-Financière (DPEF)– le Rapport sur le Gouvernement d’Entreprise– l’Examen de la situation financière et du résultat 2019Pièce jointePublication du Rapport Financier Annuel 2019

Chicago, IL, April 22, 2020 (GLOBE NEWSWIRE) — PureCircle (LSE: PURE), the world’s leading producer and innovator of great-tasting stevia ingredients for the global beverage and food industries, is pleased to announce it is now offering its proprietary NSF-02® stevia flavor solution directly to its customers. This important PureCircle solution was previously distributed by a third party as a strategic option within PureCircle’s growing natural flavor portfolio. PureCircle is now able to provide food and beverage companies as well as flavor houses direct purchase of, and access to, the ingredient.  Protected by PureCircle’s intellectual property, the NSF-02® stevia solution is part of the company’s robust portfolio of stevia leaf ingredients including sweeteners, flavor modifiers and functional ingredients.The NSF-02® stevia flavor...

First FDA-approved antibody-drug conjugate that targets the Trop-2 antigenTrodelvy is the first antibody-drug conjugate approved by FDA specifically for the treatment of relapsed or refractory metastatic triple-negative breast cancerCompany to host conference call today at 5:00 p.m. Eastern TimeMORRIS PLAINS, N.J., April 22, 2020 (GLOBE NEWSWIRE) — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy™ (sacituzumab govitecan-hziy) for the treatment of adult patients with metastatic triple-negative breast cancer (TNBC) who have received at least two prior therapies for metastatic disease. Trodelvy is the first ADC approved by the FDA specifically for...

Highlights:Contribute New and Profitable Revenues to Company Earnings Following LaunchHybrid Subscription and Advertising Business Model to Drive Revenue GrowthNew Service to Feature Original and Exclusive Content Produced by CompanyDriven by Company’s Patented and Proprietary Mobile Technology Leveraging 5G Mobile TechnologyABQQ.tv to Capture Market Share in China’s Multi-Billion Dollar and Growing Video Streaming IndustryHONG KONG and NEW YORK, April 22, 2020 (GLOBE NEWSWIRE) — AB International Group Corp. (Stock Ticker: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today announced it has nearly completed the first phase development of its highly anticipated video streaming service targeting China’s multi-billion dollar and growing video streaming industry and expects a full launch this year.  The...

COLUMBUS, Ohio, April 22, 2020 (GLOBE NEWSWIRE) — L Brands, Inc. (NYSE: LB) today announced that Sycamore Partners delivered a notice on April 22, 2020 purporting to terminate the Feb. 20, 2020 transaction agreement  (“Transaction Agreement”) relating to the sale of a 55% interest in Victoria’s Secret Lingerie, Victoria’s Secret Beauty and PINK (collectively, Victoria’s Secret) announced on Feb. 20, 2020.  Sycamore Partners also filed a lawsuit in the Court of Chancery of the State of Delaware on April 22, 2020 seeking a declaratory judgment that its termination of the Transaction Agreement is valid.  L Brands believes that Sycamore Partners’ purported termination of the Transaction Agreement is invalid.  L Brands will vigorously defend the lawsuit and pursue all legal remedies to enforce its contractual rights, including the right...